Here you find Investor News of year 2000.
In year 2000 no Ad-hoc messages have been issued.
Publications of the previous years are offered in the Archive Overview.
To view the PDF documents you will need the Acrobat Reader. Please click here to download the free Adobe Acrobat Reader software.
Receive our IR news via E-Mail, RSS Feed or SMS.
December 19, 2000 | Bayer and Lyondell to build production facility in Rotterdam
|
December 08, 2000 | Bayer not working on takeover defense
|
December 06, 2000 | Bayer set to become world's leading manufacturer of polycarbonate with Makrolon
|
November 17, 2000 | Bayer Signs Hemophilia Gene Therapy Deal with Avigen
|
November 16, 2000 | A very successful first three quarters
|
November 10, 2000 | Third Quarter 2000 Consensus Estimate
|
November 08, 2000 | ALKA-SELTZER PLUS LIQUI-GELS AND ALKA-SELTZER ANTACIDS ARE PPA-FREE
|
November 06, 2000 | New Drug Application Filed for Intravenous Formulation of the Antibiotic Moxifloxacin in Treating Community-Acquired Respiratory Tract Infections
|
October 25, 2000 | Bayer makes its capital instruments more flexible
|
October 24, 2000 | Bayer: Acquisition of Sybron Chemicals successfully completed
|
October 24, 2000 | MILLENNIUM AND BAYER INDUSTRIALIZING DRUG DISCOVERY PROCESS THROUGH ONGOING SUCCESSFUL RESEARCH ALLIANCE
|
October 17, 2000 | Bayer acquires new fungicide from Novartis
|
October 16, 2000 | H.C. Starck acquires U.S. group CSM |
October 16, 2000 | LION bioscience and Bayer Pioneer Linkage Between Chemistry & Genomics To Speed Life Science Discovery Research
|
October 11, 2000 | Bayer and DuPont to build new PBT polymer plant# |
September 14, 2000 | Bayer Supervisory Board extends CEO's contract
|
September 05, 2000 | Bayer to acquire paper chemicals business of Cytec Industries Inc.
|
September 04, 2000 | Bayer acquires antibiotic in France from Aventis and Yamanouchi
|
August 30, 2000 | Bayer to Acquire Sybron Chemicals Inc.,U.S. Producer of Polymers and Specialty Chemicals
|
August 30, 2000 | Calcium Channel Blockers Reduce Cardiovascular Risk in Hypertension, a WHO / ISH Analysis Says
|
August 16, 2000 | Development of a Recombinant Aerosol Formulation for AAT Deficiency |
August 11, 2000 | Bayer sells Solar subsidiary to SolarWorld |
August 08, 2000 | 1st Half 2000 Consensus Estimate
|
August 07, 2000 | KOGENATE Bayer approved by the European Commission
|
July 18, 2000 | Bayer awards worldwide license rights for moxifloxacin for the treatment of eye and ear infections
|
June 28, 2000 | FDA Approves Bayer's Next Generation Formulation of Recombinant Factor VIII (rFVIII) for Hemophilia A
|
June 26, 2000 | New marketplace for logistics services
|
June 14, 2000 | Bayer divests U.S. livestock vaccines business unit
|
June 02, 2000 | Calcium antagonists save lives in hypertensive patients with additional risk factors: ADALAT INSIGHT trial results
|
May 26, 2000 | Bayer plans to sell Erdölchemie shareholding to Deutsche BP
|
You are leaving the Bayer AG website.
Bayer AG is not responsible for the information on the website to which you are linking.
collect